Expand BEAM Menu
BEAM MENU

BEAM Latest Press Releases

-- December 18, 2025 --

Beam Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 4:01 PM

-- December 9, 2025 --

Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions PRNewswire 11:58 AM

-- December 6, 2025 --

Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting Globe Newswire 8:00 AM

-- November 12, 2025 --

Beam Therapeutics to Participate in 2025 Jefferies London Healthcare Conference Globe Newswire 7:00 AM

-- November 4, 2025 --

Beam Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates Globe Newswire 7:00 AM

-- November 3, 2025 --

Beam Therapeutics to Present Updated Data from BEACON Phase 1/2 Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting Globe Newswire 9:00 AM

-- August 25, 2025 --

Beam Therapeutics to Participate in Upcoming September 2025 Investor Conferences Globe Newswire 7:00 AM

-- August 14, 2025 --

Beam Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to BEAM-101 for the Treatment of Sickle Cell Disease Globe Newswire 7:00 AM

-- August 5, 2025 --

Beam Therapeutics Reports Second Quarter 2025 Financial Results and Provides Update on BEAM-302 Development Progress in Alpha-1 Antitrypsin Deficiency (AATD) Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes